Safety and Efficacy of APG-157 in Head and Neck Cancer

Clinical trial NCT05312710 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05312710
Sponsor: Aveta Biomics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma of Oral Cavity Squamous Cell Carcinoma of the Oropharynx

Start date: 2022-04-22
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.